Biolink Life Sciences, Inc.
CAGE Code: 1WR74
NCAGE Code: 1WR74
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 031254357
Summary
Biolink Life Sciences, Inc. is an Active Commercial Supplier with the Cage Code 1WR74 and is tracked by Dun & Bradstreet under DUNS Number 031254357..
Address
250 Quade Dr
Cary NC 27513-7402
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Locums Co The Encompass Southern Exposure Benco Inc Dba Bens Jamaician National Electrostatic Technologies Scoutco, Llc Bayless And Associates Pex Management And Development, Llc Nano2wear Llc Aim Enterprise Inc Blanchette Madonna D Aardwolf International Llc Durex International Corp. Aidco Co Petroleum Equipment Solutions Inc Ap Smith Community Partners A Doorway To Hope, Inc. Toner Solutions A B Kelly Inc Procom Services America, Inc.
Frequently Asked Questions (FAQ) for CAGE 1WR74
- What is CAGE Code 1WR74?
- 1WR74 is the unique identifier used by NATO Organizations to reference the physical entity known as Biolink Life Sciences, Inc. located at 250 Quade Dr, Cary NC 27513-7402, United States.
- Who is CAGE Code 1WR74?
- 1WR74 refers to Biolink Life Sciences, Inc. located at 250 Quade Dr, Cary NC 27513-7402, United States.
- Where is CAGE Code 1WR74 Located?
- CAGE Code 1WR74 is located in Cary, NC, USA.
Contracting History for CAGE 1WR74 Most Recent 25 Records
- 75A50122C00068
- Biolink - To Investigate And Determine If Treatment With Ramatroban, Administered For 28 Days To Hospitalized, Non-Icu Patients With Covid-19 Pneumonia, Reduces The Risk Of Subsequent Development Of Pasc Over The Ensuing 11 Months. Provided Data
- 16 Feb 2023
- Biolink - To Investigate And Determine If Treatment With Ramatroban, Administered For 28 Days To Hospitalized, Non-Icu Patients With Covid-19 Pneumonia, Reduces The Risk Of Subsequent Development Of Pasc Over The Ensuing 11 Months. Provided Data
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $750,000.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00068
- Biolink - To Investigate And Determine If Treatment With Ramatroban, Administered For 28 Days To Hospitalized, Non-Icu Patients With Covid-19 Pneumonia, Reduces The Risk Of Subsequent Development Of Pasc Over The Ensuing 11 Months. Provided Data
- 2 Nov 2023
- Biolink - To Investigate And Determine If Treatment With Ramatroban, Administered For 28 Days To Hospitalized, Non-Icu Patients With Covid-19 Pneumonia, Reduces The Risk Of Subsequent Development Of Pasc Over The Ensuing 11 Months. Provided Data
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $750,000.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00068
- Biolink - To Investigate And Determine If Treatment With Ramatroban, Administered For 28 Days To Hospitalized, Non-Icu Patients With Covid-19 Pneumonia, Reduces The Risk Of Subsequent Development Of Pasc Over The Ensuing 11 Months. Provided Data
- 21 Sep 2022
- Biolink - To Investigate And Determine If Treatment With Ramatroban, Administered For 28 Days To Hospitalized, Non-Icu Patients With Covid-19 Pneumonia, Reduces The Risk Of Subsequent Development Of Pasc Over The Ensuing 11 Months. Provided Data
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $750,000.00
- Department Of Health And Human Services (Hhs)